Skip to main content

letter

. 1995 Apr 15;310(6985):1002. doi: 10.1136/bmj.310.6985.1002

Screening for breast cancer. Recommendations are costly and short sighted.

PMCID: PMC2549369 PMID: 7727991

1002

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Field S., Michell M. J., Wallis M. G., Wilson A. R. What should be done about interval breast cancers? BMJ. 1995 Jan 28;310(6974):203–204. doi: 10.1136/bmj.310.6974.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
Hakama M., Holli K., Isola J., Kallioniemi O. P., Kärkkäinen A., Visakorpi T., Pukkala E., Saarenmaa I., Geiger U., Ikkala J. Aggressiveness of screen-detected breast cancers. Lancet. 1995 Jan 28;345(8944):221–224. doi: 10.1016/s0140-6736(95)90223-6. [DOI] [PubMed] [Google Scholar]
Thomas B. A. Population breast cancer screening: theory, practice, and service implications. Lancet. 1995 Jan 28;345(8944):205–207. doi: 10.1016/s0140-6736(95)90217-1. [DOI] [PubMed] [Google Scholar]
Woodman C. B., Threlfall A. G., Boggis C. R., Prior P. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ. 1995 Jan 28;310(6974):224–226. doi: 10.1136/bmj.310.6974.224. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES